<DOC>
	<DOCNO>NCT02271893</DOCNO>
	<brief_summary>The aim study ass dextromethorphan administer 4 week induce decrease pain intensity breast cancer patient suffer chemotherapy-induced peripheral neuropathy compare placebo group .</brief_summary>
	<brief_title>Dextromethorphan Chemotherapy-induced Peripheral Neuropathy Management</brief_title>
	<detailed_description>This randomize , placebo-controlled , double-blind , parallel-group clinical trial compare dextromethorphan placebo treatment chemotherapy-induced peripheral neuropathy , assess ( 0-10 ) numerical scale . Cognition , anxiety , depression , sleep quality life also assess . The influence CYP2D6 , CYP3A4 MDR1 polymorphism dextromethorphan analgesic efficacy measure .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<criteria>Age ≥ 18 year Breast cancer patient suffer chemotherapyinduced peripheral neuropathy least 3 month end last cancer chemotherapy Numerical rating scale ≥ 4 Patient stable clinical situation next month ( surgery , radiotherapy , hormone therapy , chemotherapy treatment schedule month follow enrollment ) Patients affiliated French Social Security Patients free inform consent obtain Hypersensitivity active substance excipients Hypertension History stroke Severe heart failure Severe hepatic impairment Shortness breath Congenital galactosemia , glucosegalactose malabsorption , lactase deficiency Association linezolid Preexistence history peripheral neuropathy due cause different neurotoxic chemotherapy Diabetes ( type I II ) Medical surgical history incompatible study Patient receive treatment amantadine , ketamine , memantine , LDopa , dopaminergic agonist , anticholinergic , barbiturate , neuroleptic , Monoamine oxidase inhibitor , dantrolene baclofen , phenytoin , cimetidine , ranitidine , procainamide , quinidine , quinine , amiodarone , fluoxetine , paroxetine , propafenone , thioridazine , ritonavir , nicotine , hydrochlorothiazide , warfarin Present past psychotropic substance alcohol dependence Childbearing age , use effective contraceptive method , pregnancy lactation Patient exclusion period , total allowable compensation exceed Patients undergoing measure legal protection ( guardianship , supervision ... )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Chemotherapy-induced peripheral neuropathy</keyword>
</DOC>